Holding(s) in Company
Seneca Partners Limited has notified SkinBioTherapeutics PLC of a change in its major holding, with its voting rights decreasing from 9.9% to 4.08% as of January 14, 2026. This reduction, representing 10,561,405 voting rights, is attributed to an orderly sell-down over several years and dilution from increases in the issuer's share capital, with the 5% threshold being crossed on the notification date. The previous notification was made on April 19, 2021.
Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes
Issuer Details
ISIN
GB00BF33H870
Issuer Name
SKINBIOTHERAPEUTICS PLC
UK or Non-UK Issuer
UK
Reason for Notification
An acquisition or disposal of voting rights
Details of person subject to the notification obligation
Name
SENECA PARTNERS LIMITED
City of registered office (if applicable)
Country of registered office (if applicable)
UK
Details of the shareholder
PLATFORM SECURITIES NOMINEES LIMITED
WOODSIDE NOMINEES LIMITED
City of registered office (if applicable)
LONDON
Country of registered office (if applicable)
UK
Date on which the threshold was crossed or reached
14-JAN-2026
Date on which Issuer notified
15-JAN-2026
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 4.08 | 0.000000 | 4.08 | 10,561,405 |
| Position of previous notification (if applicable) | 9.9 | 0.000000 | 9.9 | 15,604,406 |
| 8A. Voting rights attached to shares | ||||
| Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
| GB00BSVYN304 | 10,561,405 | 4.08 | ||
| Sub Total 8.A | 10,561,405 | 4.08 | ||
Financial Instruments according to (DTR5.3.1R.(1) (a))
Sub Total 8.B1
- Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Sub Total 8.B2
- Information in relation to the person subject to the notification obligation
- In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional Information
The previous notification at 9.9% was made on 19 April 2021. The decrease to the current position reflects an orderly sell-down over several years and dilution resulting from increases in the issuer's share capital, with the 5% threshold crossed on 14 January 2026.
- Date of Completion
- Place Of Completion
Haydock UK
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.